missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human VSIG4 (aa 20-283) Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Marke: R&D Systems™ 4646-VS-050
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human VSIG4 Fc Chimera at 5 μg/mL (100 μL/well) can bind complement component iC3b with an apparent Kd <20 nM.Spezifikation
| Q9Y279 | |
| Lyophilized from a 0.2 μm filtered solution in PBS. | |
| M.W. (Observed): 60-70 kDa, reducing conditions; M.W. (theoretical): 55.8 kDa (monomer) | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
| <0.10 EU / 1 μg of the protein by the LAL method. | |
| Unconjugated | |
| Reconstitute at 500 μg/mL in PBS. | |
| VSIG4 |
| Bioactivity | |
| 11326 | |
| VSIG4 Fc Chimera | |
| Mouse myeloma cell line, NS0-derived human VSIG4 protein Human VSIG4 (Arg20-Pro283) (N-terminus) Accession # Q9Y279 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) | |
| Disulfide-linked homodimer | |
| VSIG4 | |
| Recombinant | |
| >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur